Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-05

FDA Approved: CAPECITABINE — Original Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved the original application for capecitabine by BluePoint Laboratories, enabling a generic version of the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)

Snippet

ORIG AP for CAPECITABINE (CAPECITABINE)